People | October 16, 2023
Zydus appoints Punit Patel as President and CEO, Americas
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
He will be responsible for leading all the activities related to the Research & Development (Formulations) Division of the company
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
The launch of Elores in Ecuador is expected to open the doors for the entry of the novel antibiotic adjuvant entity in other important Latin American countries
Lupin is exclusive first-to-file and may be eligible to receive a 180-day exclusivity period at product launch
Astria will assume full cost and responsibility for the global development and commercialization of the licensed therapeutic program for all indications
The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials
Lokavant provides clinical trial intelligence
Tolvaptan Tablets (RLD Jynarque) had estimated annual sales of USD 287 million in the U.S. (IQVIA MAT August 2023)
Subscribe To Our Newsletter & Stay Updated
